Evaluation of colistin susceptibility in multidrug-resistant clinical isolates from cystic fibrosis, France

[1]  J. Buer,et al.  Stenotrophomonas maltophilia in cystic fibrosis: improved detection by the use of selective agar and evaluation of antimicrobial resistance. , 2011, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[2]  L. Saiman,et al.  Colistin susceptibility testing: evaluation of reliability for cystic fibrosis isolates of Pseudomonas aeruginosa and Stenotrophomonas maltophilia. , 2010, The Journal of antimicrobial chemotherapy.

[3]  J. Karakaya,et al.  Comparison of different antimicrobial susceptibility testing methods for Stenotrophomonas maltophilia and results of synergy testing , 2010, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[4]  A. Somily.  Comparison of E-test and disc diffusion methods for the in vitro evaluation of the antimicrobial activity of colistin in multi-drug resistant Gram-negative Bacilli. , 2010, Saudi medical journal.

[5]  E. Koratzanis,et al.  Colistin susceptibility testing by Etest and disk diffusion methods. , 2008, International journal of antimicrobial agents.

[6]  T. Tan,et al.  Comparison of Etest, Vitek and agar dilution for susceptibility testing of colistin. , 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[7]  J. Heesemann,et al.  Pitfalls of polymyxin antimicrobial susceptibility testing of Pseudomonas aeruginosa isolated from cystic fibrosis patients. , 2004, The Journal of antimicrobial chemotherapy.

[8]  A. Gales,et al.  In vitro susceptibility of Stenotrophomonas maltophilia isolates: comparison of disc diffusion, Etest and agar dilution methods. , 2004, The Journal of antimicrobial chemotherapy.

[9]  P. Gilligan,et al.  Laboratory Aspects of Management of Chronic Pulmonary Infections in Patients with Cystic Fibrosis , 2003, Journal of Clinical Microbiology.

[10]  Gerald B. Pier,et al.  Lung Infections Associated with Cystic Fibrosis , 2002, Clinical Microbiology Reviews.

[11]  Ronald N. Jones,et al.  Contemporary Assessment of Antimicrobial Susceptibility Testing Methods for Polymyxin B and Colistin: Review of Available Interpretative Criteria and Quality Control Guidelines , 2001, Journal of Clinical Microbiology.

[12]  J. Elborn,et al.  A ten year review of colomycin. , 2000, Respiratory medicine.

[13]  A. Levin,et al.  Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  J. Emerson,et al.  Microbiology of sputum from patients at cystic fibrosis centers in the United States. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  K. Kerr,et al.  Microbiological and Clinical Aspects of Infection Associated with Stenotrophomonas maltophilia , 1998, Clinical Microbiology Reviews.

[16]  F. Baquero,et al.  Stenotrophomonas maltophilia in cystic fibrosis patients , 1995, European Journal of Clinical Microbiology and Infectious Diseases.

[17]  R. Spencer.  The emergence of epidemic, multiple-antibiotic-resistant Stenotrophomonas (Xanthomonas) maltophilia and Burkholderia (Pseudomonas) cepacia. , 1995, The Journal of hospital infection.

[18]  N. Palleroni,et al.  Stenotrophomonas, a new bacterial genus for Xanthomonas maltophilia (Hugh 1980) Swings et al. 1983. , 1993, International journal of systematic bacteriology.

[19]  M. Thomassen,et al.  Occurrence and antimicrobial susceptibility of gram-negative nonfermentative bacilli in cystic fibrosis patients. , 1985, Diagnostic microbiology and infectious disease.

[20]  J. Turnidge,et al.  Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria. , 2005, International journal of antimicrobial agents.

[21]  C. Soussy,et al.  Comité de l'Antibiogramme de la Société Française de Microbiologie report 2003. , 2003, International journal of antimicrobial agents.

[22]  J. Andrews.  BSAC WORKING PARTY ON SUSCEPTIBILITY TESTING FT. BSAC STANDARDIZED DISC SUSCEPTIBILITY TESTING METHOD , 2001 .

[23]  J. Andrews.  BSAC standardized disc susceptibility testing method. , 2001, The Journal of antimicrobial chemotherapy.

[24]  L. Tsui,et al.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. , 1989, Science.

[25]  J. Gustafson,et al.  Cystic Fibrosis , 2009, Journal of the Iowa Medical Society.